Literature DB >> 33373529

Generation of Keratinocytes from Human Induced Pluripotent Stem Cells Under Defined Culture Conditions.

Shyam Kishor Sah1, Jitendra K Kanaujiya1, I-Ping Chen2, Ernst J Reichenberger1.   

Abstract

Differentiation of keratinocytes from human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) has become an important tool for wound healing research and for studying skin diseases in instances where patient cells are not available. Several keratinocyte differentiation protocols using hiPSC colony fragments or embryoid bodies have been published with some requiring prolonged time for differentiation or extended use of reagent cocktails. In this study, we present a simplified method to efficiently generate large numbers of uniformly differentiated keratinocytes in less than 4 weeks from singularized hiPSCs with differentiation factors, retinoic acid and bone morphogenetic protein 4 (BMP4). Low seeding density of singularized iPSCs results in keratinocyte cultures with minimum cell death during differentiation and up to 96% homogeneity for keratin 14-positive cells and low percentage of keratinocyte maturation markers, comparable to early passage primary keratinocytes. hiPSC-derived keratinocytes remain in a proliferative state, can be maintained for prolonged periods of time, and can be terminally differentiated under high calcium conditions in the same way as primary human keratinocytes. Moreover, coculturing hiPSC-derived fibroblasts and keratinocytes consistently formed organotypic 3D skin equivalents. Therefore, keratinocytes generated by this method are a viable source of cells for downstream applications.

Entities:  

Keywords:  differentiation; human induced pluripotent stem cells; keratinocyte; method

Mesh:

Substances:

Year:  2020        PMID: 33373529      PMCID: PMC8665820          DOI: 10.1089/cell.2020.0046

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  46 in total

1.  Induced pluripotent stem cell-derived melanocyte precursor cells undergoing differentiation into melanocytes.

Authors:  Chieko Hosaka; Makoto Kunisada; Michiyo Koyanagi-Aoi; Taro Masaki; Chihiro Takemori; Mariko Taniguchi-Ikeda; Takashi Aoi; Chikako Nishigori
Journal:  Pigment Cell Melanoma Res       Date:  2019-03-25       Impact factor: 4.693

2.  CRISPR/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells.

Authors:  Joanna Jacków; Zongyou Guo; Corey Hansen; Hasan E Abaci; Yanne S Doucet; Jung U Shin; Ryota Hayashi; Dominick DeLorenzo; Yudai Kabata; Satoru Shinkuma; Julio C Salas-Alanis; Angela M Christiano
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-09       Impact factor: 11.205

Review 3.  Methods for cultivation of keratinocytes with an air-liquid interface.

Authors:  M Pruniéras; M Régnier; D Woodley
Journal:  J Invest Dermatol       Date:  1983-07       Impact factor: 8.551

4.  Differentiation of human embryonic stem cells into clinically amenable keratinocytes in an autogenic environment.

Authors:  Fahad K Kidwai; Hua Liu; Wei Seong Toh; Xin Fu; Doorgesh S Jokhun; Mohammad M Movahednia; Mingming Li; Yu Zou; Christopher A Squier; Toan T Phan; Tong Cao
Journal:  J Invest Dermatol       Date:  2012-12-13       Impact factor: 8.551

5.  Induced pluripotent stem cell reprogramming by integration-free Sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia.

Authors:  I-Ping Chen; Keiichi Fukuda; Noemi Fusaki; Akihiro Iida; Mamoru Hasegawa; Alexander Lichtler; Ernst J Reichenberger
Journal:  Cell Reprogram       Date:  2013-11-12       Impact factor: 1.987

6.  Three clonal types of keratinocyte with different capacities for multiplication.

Authors:  Y Barrandon; H Green
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

7.  Epigenetic and phenotypic profile of fibroblasts derived from induced pluripotent stem cells.

Authors:  Kyle J Hewitt; Yulia Shamis; Ryan B Hayman; Mariam Margvelashvili; Shumin Dong; Mark W Carlson; Jonathan A Garlick
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

8.  Generation of human melanocytes from induced pluripotent stem cells.

Authors:  Shigeki Ohta; Yoichi Imaizumi; Yohei Okada; Wado Akamatsu; Reiko Kuwahara; Manabu Ohyama; Masayuki Amagai; Yumi Matsuzaki; Shinya Yamanaka; Hideyuki Okano; Yutaka Kawakami
Journal:  PLoS One       Date:  2011-01-13       Impact factor: 3.240

9.  Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141+ Subset.

Authors:  Patty Sachamitr; Alison J Leishman; Timothy J Davies; Paul J Fairchild
Journal:  Front Immunol       Date:  2018-01-08       Impact factor: 7.561

10.  Homogeneous monocytes and macrophages from human embryonic stem cells following coculture-free differentiation in M-CSF and IL-3.

Authors:  Karl R Karlsson; Sally Cowley; Fernando O Martinez; Michael Shaw; Stephen L Minger; William James
Journal:  Exp Hematol       Date:  2008-06-11       Impact factor: 3.084

View more
  2 in total

1.  Clinical Grade Human Pluripotent Stem Cell-Derived Engineered Skin Substitutes Promote Keratinocytes Wound Closure In Vitro.

Authors:  Sophie Domingues; Annabelle Darle; Yolande Masson; Manoubia Saidani; Emilie Lagoutte; Ana Bejanariu; Julien Coutier; Raif Eren Ayata; Marielle Bouschbacher; Marc Peschanski; Gilles Lemaitre; Christine Baldeschi
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

Review 2.  CRISPR-Cas9‒Based Genomic Engineering in Keratinocytes: From Technology to Application.

Authors:  Jos P H Smits; Luca D Meesters; Berber G W Maste; Huiqing Zhou; Patrick L J M Zeeuwen; Ellen H van den Bogaard
Journal:  JID Innov       Date:  2021-12-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.